Booth: Country/Region: China Mainland
Zhuhai Gene-Biocon Biological Technology Co., Ltd. was founded in 2015, located in Golden Coast Biomedical Science and Technology Park, Jinwan District, Zhuhai City, P. R. China. The company specializes in R&D and technical services of biological products, as well as production and marketing of cosmetic peptides, genetically engineered enzymes and cell growth factors. The company is a national high technology enterprise, Guangdong scientific and technological small and medium-sized enterprise, Zhuhai new type R&D organization, and innovation-driven enterprise of Jinwan District in Zhuhai City.
The company's team is composed of a number of High-level Talents and Outstanding Young Talents, including the industry's top " Thousand Talents Scheme " experts, with rich experience in biomedical product R&D and industrialization. The company has established in-depth Industry-University-Research Cooperation with Sun Yat-sen University, South China University of Technology, Macao University, Tsinghua University Shenzhen Graduate School, Southern Medical University, Zunyi Medical University, Jilin University Zhuhai College and other scientific research institutes.
The company is strong in technology, established standardized Bio-pharmaceutical R&D laboratory and GMP standard pilot scale workshop, has the ability in R&D, pilot-scale production, and registration submission for biological raw materials, intermediates and finished products. Established the cosmetic polypeptide R&D center and the production workshop, has the ability in raw material formula research and the high-tech cosmetic polypeptide production. The company has a well-functioning quality control center and a robust quality management system, and is capable in quality study, biological activity testing, and efficacy testing.
The company is committed to becoming the leading expert in fermentation, synthesis and natural extraction of cosmetic raw materials in China and to be a high-level manufacturer of biopharmaceutical raw materials and new generation diabetes treatment products by using its genetic engineering technology advantages.